(Q31943770)

5 July 2017

title

The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway (English)

1 reference

5 July 2017

1 reference

3

Hellström PM

1 reference

5 July 2017

Tolessa T

1

1 reference

5 July 2017

Näslund E

series ordinal

2

1 reference

5 July 2017

publication date

1 April 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

98

1 reference

5 July 2017

issue

1-2

1 reference

5 July 2017

page(s)

33-40

1 reference

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Glucagon and its family revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Characteristics of fasting and fed myoelectric activity in rat small intestine: evaluation by computer analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Ileal release of glucagon-like peptide-1 (GLP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Gastric emptying and release of incretin hormones after glucose ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Nitrergic inhibition of migrating myoelectric complex in the rat is mediated by vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Glucagon.glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Expression cloning and signaling properties of the rat glucagon receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Role of NO in vagally-mediated relaxations of guinea-pig stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Nerve-induced release of nitric oxide in the rabbit gastrointestinal tract as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900220-2

7 January 2021

10.1016/S0167-0115(00)00220-2

Identifiers

DOI

1 reference

5 July 2017

1 reference